Alnylam Pharmaceuticals (ALNY)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 1 |
| Ownership rank: | 866 |
| % of all portfolios: | 0.004% |
| History | Portfolio Manager | Activity ▲ | Share change | % change to portfolio | |
| Q2 2026 | |||||
| ≡ | Dodge & Cox Funds | Add 1.35% | 26,140 | 0.00 | |
| Q1 2026 | |||||
| ≡ | Dodge & Cox Funds | Reduce 1.79% | 35,162 | 0.01 | |
| Q4 2025 | |||||
| ≡ | Dodge & Cox Funds | Reduce 15.37% | 356,815 | 0.08 | |
| ≡ | Polen Capital Management | Sell 100.00% | 693 | 0.00 | |
| Q3 2025 | |||||
| ≡ | Polen Capital Management | Buy | 693 | 0.00 | |
| ≡ | Dodge & Cox Funds | Reduce 27.40% | 875,866 | 0.22 | |
| Q2 2025 | |||||
| ≡ | Dodge & Cox Funds | Reduce 4.61% | 154,666 | 0.03 | |
| Q1 2025 | |||||
| ≡ | Dodge & Cox Funds | Reduce 5.32% | 188,500 | 0.03 | |
| Q4 2024 | |||||
| ≡ | Dodge & Cox Funds | Reduce 2.27% | 82,273 | 0.01 | |
| Q3 2024 | |||||
| ≡ | Dodge & Cox Funds | Reduce 4.17% | 157,650 | 0.02 | |
| Q2 2024 | |||||
| ≡ | Dodge & Cox Funds | Reduce 0.82% | 31,295 | 0.00 | |
| Q4 2021 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Sell 100.00% | 3,983 | 0.01 | |
| Q3 2021 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Reduce 98.64% | 288,700 | 0.72 | |
| Q2 2021 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Reduce 63.24% | 503,551 | 0.81 | |
| Q1 2021 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Reduce 19.12% | 188,268 | 0.25 | |
| Q4 2020 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Add 1.76% | 17,041 | 0.04 | |
| Q3 2020 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Reduce 13.12% | 146,147 | 0.40 | |
| Q2 2020 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Reduce 16.88% | 226,097 | 0.70 | |
| ≡ | First Eagle Investment Management | Sell 100.00% | 26,500 | 0.01 | |
| Q1 2020 | |||||
| ≡ | First Eagle Investment Management | Buy | 26,500 | 0.01 | |
| ≡ | Lee Ainslie - Maverick Capital | Reduce 40.74% | 921,192 | 2.12 | |
| Q4 2019 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Reduce 29.85% | 961,916 | 1.61 | |
| Q3 2019 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Reduce 23.92% | 1,013,203 | 1.20 | |
| Q2 2019 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Add 31.95% | 1,025,629 | 1.08 | |
| Q1 2019 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Add 14.50% | 406,436 | 0.50 | |
| Q4 2018 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Add 85.44% | 1,291,887 | 1.38 | |
| Q3 2018 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Add 121.92% | 830,710 | 0.91 | |
| Q2 2018 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Buy | 681,354 | 0.78 | |
| Q2 2013 | |||||
| ≡ | Thomas Russo - Gardner Russo & Quinn | Sell 100.00% | 75 | 0.00 | |
| Q1 2013 | |||||
| ≡ | Thomas Russo - Gardner Russo & Quinn | Buy | 75 | 0.00 | |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.